“The outlook revision reflects our view of BCH’s challenged operations over the past several years, including very poor operating margins in fiscal 2015,” said S&P credit analyst Allison Bretz.
S&P also affirmed the “AA+/A-1” rating on BCH’s series 2000 revenue bonds.
More articles on healthcare finance:
Covenant Health taps Cerner for integrated RCM platform
Medicare’s top 20 costliest drugs
Hospital cost, quality ranking site aims to help employers manage costs
